1 |
Li Y, Li J, He T, Song Y, Wu J, Wang B. Significance of Identifying Key Genes Involved in HBV-Related Hepatocellular Carcinoma for Primary Care Surveillance of Patients with Cirrhosis. Genes (Basel) 2022;13. [PMID: 36553600 DOI: 10.3390/genes13122331] [Reference Citation Analysis]
|
2 |
Yao J, Ma C, Feng K, Tan G, Wen Q. Focusing on the Role of Natural Products in Overcoming Cancer Drug Resistance: An Autophagy-Based Perspective. Biomolecules 2022;12:1565. [DOI: 10.3390/biom12111565] [Reference Citation Analysis]
|
3 |
Gao S, Jiang X, Wang L, Jiang S, Luo H, Chen Y, Peng C. The pathogenesis of liver cancer and the therapeutic potential of bioactive substances. Front Pharmacol 2022;13:1029601. [DOI: 10.3389/fphar.2022.1029601] [Reference Citation Analysis]
|
4 |
Wang J, Miao Y, Li L, Wu Y, Ren Y, Cui Y, Cao H. Multi-omics data integration for hepatocellular carcinoma subtyping with multi-kernel learning. Front Genet 2022;13:962870. [DOI: 10.3389/fgene.2022.962870] [Reference Citation Analysis]
|
5 |
Lv F, Li X, Wang Y. Lycorine inhibits angiogenesis by docking to PDGFRα. BMC Cancer 2022;22:873. [PMID: 35948939 DOI: 10.1186/s12885-022-09929-y] [Reference Citation Analysis]
|
6 |
Javed A, Malagraba G, Yarmohammadi M, Perelló-reus CM, Barceló C, Rubio-tomás T. Therapeutic Potential of Mitotic Kinases’ Inhibitors in Cancers of the Gastrointestinal System. Future Pharmacology 2022;2:214-237. [DOI: 10.3390/futurepharmacol2030015] [Reference Citation Analysis]
|
7 |
Regmi P, He Z, Lia T, Paudyal A, Li F. N7-Methylguanosine Genes Related Prognostic Biomarker in Hepatocellular Carcinoma. Front Genet 2022;13:918983. [DOI: 10.3389/fgene.2022.918983] [Reference Citation Analysis]
|